beta
KERX
Keryx Biopharmaceuticals Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Keryx Biopharmaceuticals Inc acquires and develops novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.
Market Cap: 540 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.keryx.com
Shares Outstanding: 119 Million
Float: 112 Million
Dividend: 0.0 (0.0%)
Beta: 2.665747
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1270 trading days
From: 2014-08-29 To: 2018-12-12
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|